Merck stock up on Q2 earnings beat, Pfizer revenue declines on falling COVID vaccine demand

#Merck #Pfizer #youtube
Pharmaceutical company Merck saw revenue boosted in Q2 earnings amid M&A moves and surging profits from name-brand drugs. Pfizer, on the other hand, reported declining revenues attributed to falling demand for COVID-19 vaccines. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the earnings data from the two pharma giants.

About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more.

Connect with Yahoo Finance: